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Introduction {#sec1}
============

Profound neuronal and synaptic loss is a hallmark of neurodegenerative disorders and is the best pathological correlate of cognitive impairment in Alzheimer\'s disease (AD) ([@bib55], [@bib52]). Restoration of depleted neuronal populations with stem cell therapy is a promising treatment strategy ([@bib14], [@bib36], [@bib18]), but the inaccessibility of endogenous neural stem cells within the brain\'s neurogenic niches means that alternative cell sources are required, preferably of autologous origin, to avoid long-term immunosuppression, which is harmful to both graft and host.

Reprogramming technology transformed the field, converting fibroblasts (FBTs) and other somatic cells into induced pluripotent stem cells (iPSCs) ([@bib54]) capable of generating functional neurons *in vivo* ([@bib60]). Alternatively, somatic cells can be converted directly into induced neurons (iNs), in effect bypassing the pluripotent state by induced upregulation of neuronal specification genes *ASCL1*, *NEUROD*, *MYTL*, and *BRN2* ([@bib39], [@bib42]). However, clinical translation of reprogramming technology remains limited for a number of reasons. First, conversion efficiency is typically very low, \<1% of initial cells for iPSCs ([@bib33]) and \<6% for iNs ([@bib39]). Second, both cell types suffer from unacceptably high line-to-line (and even clone-to-clone) variability ([@bib58]), a factor that precludes clinical translation. Third, the unlimited capacity of iPSCs to self-renew presents an inherent risk of uncontrolled cell growth *in vivo*, with high (60%) tumor rates reported ([@bib45]). Finally, genetic modification raises significant safety concerns, including activating oncogenes and the risk of unanticipated mutagenesis.

The discovery of niches within adult skin that continue to harbor multipotent stem cells raised the prospect of overcoming some of these limitations. Cell populations within these niches exhibit stem cell-like properties, distinct from mesenchymal or hematopoietic stem cells, and retain a neurogenic developmental potency without genetic manipulation, including expression of neural stem cell-related proteins such as NESTIN and SOX2 *in situ* ([@bib56], [@bib21]). Using a neurosphere propagation method, these native stem cell-like cells, termed skin-derived precursors (SKPs), can be expanded for multiple passages (\>50), and mature into neural cell types when exposed to neurodifferentiation factors ([@bib56], [@bib6], [@bib30]). However, the final neuronal yield achieved by this approach has been very low (2%--10% across studies), and the propensity for glial cell differentiation ([@bib57], [@bib25]) has generally excluded translation of SKP cells to neuronal therapeutic application.

Responding to this, we previously reported enhanced cellular homogeneity and neurogenic potential using a two-step neurosphere-adherent culture system that begins with mature adult canine skin ([@bib59]). The complex three-dimensional growth environment and uneven exposure to growth signals inherent in the neurosphere assay permits and promotes heterogeneous cell growth ([@bib5], [@bib4]), with neural stem cells reported to represent less than 1% of this population ([@bib44]). By contrast, we used neurospheres solely as a primary selection step, further expanding the resultant cells as an exclusively epidermal growth factor (EGF)/basic fibroblast growth factor (bFGF)-dependent adherent monolayer culture. Adherent expansion of human SKPs has been reported previously ([@bib27]), and while better neuronal yields were achieved using serum and astrocyte-conditioned medium, glial and mesenchymal cell types remained commonplace. Adherent culture systems have also been employed to expand brain-derived neural stem cells, producing more homogeneous cell populations biased toward GABAergic and glutamatergic neurons ([@bib10], [@bib43], [@bib22]). Combining these approaching in our two-step serum-free culture system, a unique population of skin-derived neural precursors (SKNs) can be routinely generated from adult canine skin, maturing to produce greater than 90% neuronal yields *in vitro* without genetic manipulation ([@bib59]). Accordingly, SKNs represent a promising candidate for autologous neural cell therapy.

Our choice of studying canine skin was intentional because of the poor history of translation of rodent research into effective human neurodegenerative treatment. Rodents do not naturally develop AD pathology or neurobehavioural signs in late life, and transgenic models have failed to predict outcomes in human clinical trials ([@bib12], [@bib8]). By contrast, canine cognitive dysfunction (CCD) is a naturally occurring analogue of human AD; affected dogs display a progressive amnestic syndrome ([@bib11], [@bib49]) as well as AD pathology ([@bib11]), and, as in humans, prevalence accelerates exponentially in old age ([@bib48]). CCD may therefore be an ideal translational model to test regenerative therapies. Yet prior to this, any candidate cell type needs thorough characterization. Here, we therefore assess the line-to-line replicability and neurogenic potential of canine SKNs in comparison with both canine dermal FBTs and brain-derived neural precursor cells (NPCs) isolated from the canine neurogenic niche.

Results {#sec2}
=======

SKNs Are Isolated and Expanded Using a Clinically Replicable Protocol {#sec2.1}
---------------------------------------------------------------------

Our protocol for the culture of canine SKNs combines initial neurosphere selection with passage as an adherent monolayer for cellular homogenization ([Figure 1](#fig1){ref-type="fig"}A). From an approximately 6 cm^2^ abdominal skin sample, under proliferative conditions, floating neurospheres (≈100 μm in diameter) formed in culture within 7 days of isolation ([Figure 1](#fig1){ref-type="fig"}B). Following selection of these neurospheres, and their enzymatic dissociation, the resulting cells were cultured as an adherent monolayer. A large amount of cell death occurred within the first 2 days of this adherent culture, but a selective population consisting of exclusively EGF/bFGF-maintained SKNs survived. Following first passage, approximately 1,000,000 SKNs could be routinely generated from over 50 individual skin donors (85% donor-wise success rate). The clonal ability of SKNs was demonstrated by seeding at single-cell density in a collagen matrix that precluded cell fusion, with spheres approximately 50 μm in diameter forming after 7 days of culture ([Figure 1](#fig1){ref-type="fig"}C).Figure 1SKNs Are Rate Limited *In Vitro*(A) SKN culture protocol and timing of differentiation.(B) Representative morphology of adult canine SKNs and NPCs at the neurosphere stage (top) and during subsequent adherent monolayer expansion (bottom). Scale bars, 50 μm.(C) Clonal proliferation from a single SKN cell. Scale bars, 50 μm.(D) SKNs exhibit significantly lower expression of cell division marker 5-ethynyl-2′-deoxyuridine (EDU) at passage 3 and beyond compared with adult NPCs (P3, ^∗^p = 0.02; P4, ^∗∗^p = 0.008; P5, ^∗∗^p = 0.003; n = 3 independent experiments; mean ± SEM).(E) Gene expression of master neural stem cell regulator *SOX2* in SKNs at passage 3 is intermediate between adult fibroblasts (FBT) and NPCs (^∗^p = 0.01; n = 3 independent experiments; mean ± SEM).

SKNs Demonstrate Limited Proliferative Capacity *In Vitro* {#sec2.2}
----------------------------------------------------------

Under our adherent culture conditions, a homogeneous SKN population could be routinely expanded for up to five passages. At first and second passage, 80% confluence (passage density) was reached within 7 days, undergoing an average of 2.7 population doublings, defined as \[log(final cell count/starting cell count)\]/log(2) ([@bib23]). Following third passage, proliferative rates began to decline, with only 1.4 population doublings occurring within an equivalent time frame. This decline was also quantified by 5-ethynyl-2′-deoxyuridine labeling of actively dividing cells. Initially comparable levels of active proliferation in SKNs and brain-derived NPCs significantly declined in the SKN cultures at passage 3 and beyond ([Figure 1](#fig1){ref-type="fig"}D). This observation was also consistent with *SOX2* gene expression, a regulator for stem cell proliferation, where expression in SKNs was significantly lower than in NPCs (^∗^p = 0.01; [Figure 1](#fig1){ref-type="fig"}E). Under adherent proliferative conditions, SKNs are therefore limited in terms of their proliferative capacity.

SKNs Are a Distinct Population from Dermal FBTs {#sec2.3}
-----------------------------------------------

Global transcriptome analysis was carried out on canine dermal FBTs, SKNs, and NPCs, in order to better understand the neural potential of SKNs and the general relationship between these three cell types. Principle-component analysis of 32,000 transcripts accounted for 60.1% of total transcriptomic variance, with three cell populations observed, each with distinctive expression profiles ([Figure 2](#fig2){ref-type="fig"}A). Cell lines within cell types were highly correlated (r ≥ 0.98 SKN, r ≥ 0.98 NPC, r ≥ 0.98 FBT), while globally SKN and FBT lines were more closely correlated (r range: 0.96--0.97) than SKN and NPC lines (r range: 0.92--0.94). Correlation coefficients for individual cell lines are displayed in [Table S1](#mmc1){ref-type="supplementary-material"}.Figure 2Gene Expression Patterns of SKNs Are Distinguished from FBTs or NPCs(A) Principal components analysis of global gene expression of SKN, FBT, and NPC lines showed three distinct expression patterns. Further analysis indicated that gene expression from SKNs correlate closer to gene expression from FBTs than NPCs. See also [Table S1](#mmc1){ref-type="supplementary-material"} (n = 3 independent experiments; mean ± SEM).(B) Univariate analysis shows SKNs and FBTs to have 291 differentially expressed genes and the least dissimilarities between cell types. Forty genes were expressed exclusively by SKNs. See also [Table S2](#mmc1){ref-type="supplementary-material"}.(C) Hierarchical clustering of significant differentially expressed genes based on Euclidean distance implicated that SKNs are globally closer to FBTs than NPCs.(D) qPCR showed that SKNs have significantly higher transcript expression of neural stem cell-like marker gene *NES* (^∗∗^p = 0.003), neural crest gene *P75NTR* (^∗∗^p = 0.03), neuroblast gene *DCX* (^∗∗∗^p = 0.0005), and immature neuronal gene *TUBB3* (^∗^p = 0.04) compared with FBTs (n = 3 independent experiments; mean ± SEM).

To elucidate whether underlying molecular profiles were similar between these three cell types, ANOVA was performed at a false discovery rate of \<0.05 to identify genes with a greater than 2-fold difference in normalized expression between cell types. Of the 32,000 genes analyzed, 291 genes were differentially expressed between SKNs and FBTs, while 2,157 genes were differentially expressed between SKNs and NPCs ([Figure 2](#fig2){ref-type="fig"}B). These univariate results indicate that SKNs are closer in global gene expression to FBTs than NPCs. A multivariate method of hierarchical clustering on differentially expressed genes also placed SKNs in a closer relationship to FBTs than NPCs ([Figure 2](#fig2){ref-type="fig"}C). Nevertheless, qPCR examination of specific neural stem and precursor markers showed that SKNs retain a distinct gene expression profile to FBTs, with *NES, P75NTR, DCX*, and *TUBB3* all significantly upregulated ([Figure 2](#fig2){ref-type="fig"}D). Moreover, from the Venn diagram we can infer that there are at least 40 genes specific to SKNs (detailed in [Table S2](#mmc1){ref-type="supplementary-material"}). Many of these genes are associated with cell proliferation, adhesion, migration, and cytoskeletal organization. Of particular note were genes coding for protocadherins. These cell-adhesion proteins are predominantly expressed by the developing CNS ([@bib50]), and have key roles in establishing neuronal connectivity and dendrite arborization ([@bib51], [@bib31]).

Transcript lists containing the most commonly cited genes for pluripotency, neurogenesis, SKPs, mesenchymal stem cells (MSCs), growth factors, and growth factor receptors were compared for expression intensity between SKNs and NPCs ([Figure 3](#fig3){ref-type="fig"}). A full list of the individual gene expression fold changes between SKNs and NPCs can be found in [Table S3](#mmc1){ref-type="supplementary-material"}. The iPSC pluripotency reprogramming factor *KLF4* ([@bib54], [@bib53]), and the *TBX3* gene implicated in embryonic stem cell proliferation and neuroepithelial differentiation ([@bib20]), were found to be upregulated in SKNs. Pluripotency markers *BUB1*, *TCL1A*, and *PRC1* were all upregulated in NPCs, confirming their greater proliferative capacity, as reported in [Figure 1](#fig1){ref-type="fig"}D. As expected, NPCs also showed stronger expression of neurogenesis markers. However, early neurogenesis markers *MKI67*, *PAX6*, *NCAM1*, *NES*, and *SOX2* were also strongly expressed in SKNs, indicative of a largely undifferentiated population of neural precursors. SKNs expressed the majority of SKP and MSC markers more intensely than NPCs, with significant upregulation of *PDGFRA*, *HOXA5*, *HOXC4*, *HOXC6*, *TWIST2*, *EYA1*, *MAB21L1*, *MSX1*, *RHOBTB3*, and *AP2A1*.Figure 3Gene Expression Heatmaps for NPC and SKN LinesHeatmap of (A) pluripotency, (B) neurogenesis, (C) SKP and MSC, and (D) growth factor- and receptor-associated genes comparing NPC with SKN cell lines. Gene expression fold changes are color coded to visualize highly expressed genes. High relative expression of multiple genes associated with pluripotency and neurogenesis was evident in both SKN and NPC lines, while many SKP and MSC genes were expressed to a greater degree in SKNs, indicative of their dermal origins.

Growth factor and receptor gene expression were explored in order to gain insight into factors that SKNs may produce, or be responsive to, if transplanted in the brain. Interestingly, genes for insulin-like growth factors and their receptors were highly expressed in SKNs compared with NPCs. Furthermore, expression of *IL7* and *VEGFC* were upregulated in SKNs relative to NPCs. These growth factors, while expressed in adult skin, also have key roles in both the adult and developing brain, including neurogenesis and synaptogenesis, and as migratory cues for neuronal precursors ([@bib37], [@bib13], [@bib46]). As such, they may facilitate SKN survival and engraftment following transplantation.

Pathway enrichment was then carried out on the 2,157 differentially expressed gene list (SKNs versus NPCs) and scored based on Fisher\'s exact test (p \< 0.01) to identify functional groups with more than two over-represented genes from a specific pathway. Genes were referenced against the Kyoto Encyclopedia of Genes and Genomes *C. familiaris* genome database ([@bib29]). The aim was to characterize and compare the biological pathways best represented in both cell types. Focal adhesion, extracellular matrix (ECM)-receptor interaction and PI3-AKT signaling pathway were the three most enriched pathways ([Table 1](#tbl1){ref-type="table"}). The relative gene expression in SKNs and NPCs for components of these pathways and others have been mapped in [Figures S1--S6](#mmc1){ref-type="supplementary-material"}. The focal adhesion pathway ([Figure S1](#mmc1){ref-type="supplementary-material"}), incorporating upregulated expression of p21-activated kinase proteins in SKNs, has an important role in the regulation of the actin cytoskeleton and is implicated in cell proliferation and migration, mediating filopodia formation, and cell motility ([@bib61]). Interlinked with the focal adhesion pathway, phosphatidylinositol 3-kinase-Akt signaling ([Figure S2](#mmc1){ref-type="supplementary-material"}) was also highly enriched in SKNs. An important regulator of the cell cycle, this pathway has been implicated in promoting proliferation and inhibiting differentiation in adult hippocampal NPCs ([@bib40]). Axon guidance was also identified as an enriched pathway between NPCs and SKNs ([Figure S3](#mmc1){ref-type="supplementary-material"}). Ephrins, upregulated in SKNs, have been shown to mediate growth cone survival and collapse, and play a large role in the neural crest migration during gastrulation. EPH-A in particular has also been shown to interact with P75 neurotrophin receptor (P75NTR) in axon guidance and mapping ([@bib34]). In addition, the differentially expressed gene list also contained a number of upregulated genes associated with glutamatergic and GABAergic synapse ([Figure S4](#mmc1){ref-type="supplementary-material"}) pathways, including AMP(A) and GABA(A) postsynaptic receptors, which were both upregulated in SKNs compared with NPCs. Nevertheless, these synaptic pathways in their entirety were not significantly enriched, likely due to the cells\' undifferentiated neural precursor phenotype.Table 1Pathway Enrichment Analysis of Differentially Expressed Genes in SKN Cell Lines Based on the Kyoto Encyclopedia of Genes and Genomes PathwaysPathway NameEnrichment ScoreEnrichment\
p ValuePercentage of Pathway Genes RepresentedFocal adhesion17.290.0000000324Extracellular matrix-receptor interaction16.470.0000000733PI3K-Akt signaling pathway11.900.00000619Proteoglycans in cancer9.820.0000530Dilated cardiomyopathy9.810.0000520Cell-adhesion molecules9.570.0000626Actin cytoskeleton regulation8.950.000123Hypertrophic cardiomyopathy8.890.000119Keratan sulfate glycosaminoglycan biosynthesis7.690.000426Axon guidance7.330.000647Mitogen-activated protein kinase signaling pathway7.160.000721Pathways in cancer4.950.00717Glycosphingolipid biosynthesis4.810.00815Prostate cancer4.660.00930Melanoma4.610.0120[^1]

SKNs Possess Phenotypic Stability across Cell Lines {#sec2.4}
---------------------------------------------------

As expected, embryonic pluripotency marker NANOG was not expressed. KI67 and SOX2 proliferation markers were present in a majority of SKNs (51% and 72%, respectively), and while OCT4 was highly expressed, staining was perinuclear, consistent with reported expression in dermal cells ([@bib32]) ([Figures 4](#fig4){ref-type="fig"}A and 4B). SKNs were homogeneous for stem cell-like marker CD133, neural stem/crest cell-like marker NESTIN, and neural crest cell marker P75NTR, a regulatory molecule implicated in both skin stem cell biology ([@bib1]) and neurotrophin signaling ([@bib47]) ([Figures 4](#fig4){ref-type="fig"}A and 4B). In fact, across these three distinct markers, line-to-line variance was remarkably low: fluorescence-activated cell sorting of three independent SKN lines (in triplicate) revealed \>97% expression for each marker and a between-line coefficient of variance of \<1.8%. This excellent level of line-to-line phenotypic replicability is therefore consistent with therapeutic usage.Figure 4SKNs Homogenously Express Neural Stem Cell-like and Neural Crest Cell Markers(A) Representative immunocytochemistry images of an array of pluripotency (OCT4 and NANOG), proliferation (KI67 and SOX2), neural stem/precursor cell (PAX6, NESTIN, CD133, P75NTR, SCF, PSA-NCAM, DOUBLECORTIN, BETAIII-TUBULIN), glial cell (GFAP and O4), transmembrane receptors (BETA1-INTEGRIN and ALPHA4-INTEGRIN), and mesenchymal cell markers (PDGFRA, CD44, SMA, and TFR). Nuclei were counterstained with DAPI (blue). Scale bars, 50 μm.(B) Corresponding flow cytometric quantification showed SKNs were highly homogeneous for neural stem/precursor cell markers (n = 3 independent experiments; mean ± SEM).

SKNs also highly expressed an array of neural precursor markers: polysialylated neuronal cell-adhesion molecule (PSA-NCAM), DOUBLECORTIN, and immature neuronal BETAIII-TUBULIN were present in over 85% of cells. Of note, the astrocyte marker glial fibrillary acidic protein (GFAP) and oligodendrocyte marker O4 were observed in less than 1% of cells ([Figure 4](#fig4){ref-type="fig"}A). Expression of BETA1-INTEGRIN, combined with the absence of ALPHA4-INTEGRIN expression, may indicate a propensity of SKNs to preferentially bind laminins. This supports upregulated laminin-associated genes observed within the ECM-receptor-enriched pathway ([Figure S5](#mmc1){ref-type="supplementary-material"}). Mesenchymal markers, platelet-derived growth factor receptor alpha (PDGFRA) and CD44 were found to be expressed in SKNs ([Figures 4](#fig4){ref-type="fig"}A and 4B). These proteins were found to be co-expressed with NSC markers CD133 and P75NTR within single cells ([Figure S6](#mmc1){ref-type="supplementary-material"}). Of note, PDGFRA, while classically a mesenchymal marker, is also found in neuroepithelial cells ([@bib2]) and adult neural precursors. Moreover, adult human PDGFRA-expressing neural precursors of the periventricular region do not co-express GFAP ([@bib9]), and so SKNs may share this non-glial propensity. Expression of mesenchymal myofibroblast marker smooth muscle actin was minimal. Transferrin receptor, traditionally considered a haematopoetic stem cell marker, was also observed in SKNs, although this receptor is also associated with neural cell types throughout the CNS ([@bib19]).

SKNs Are Neuronally Fate Restricted *In Vitro* {#sec2.5}
----------------------------------------------

Following passage 3, the proliferative rate of SKNs declines rapidly and their morphology increasingly comes to resemble differentiating neurons. This spontaneous neuronal differentiation was enhanced through the removal of mitogens from the culture medium and supplementation with brain-derived neurotrophic factor (BDNF), known to support neuronal differentiation. Over a 28-day differentiation period, SKNs remained viable, and developed increasingly more complex elongated processes and mature neuronal morphology ([Figure 5](#fig5){ref-type="fig"}A), significantly more frequent than in NPCs (p \< 0.0001; [Figure 5](#fig5){ref-type="fig"}B). Post-differentiation SKNs were also a more homogeneous population than NPCs. SKNs expressed neuronal marker genes *TUBB3* and *MAP2* but, unlike differentiated NPCs, glial cell *GFAP* was not expressed ([Figure 5](#fig5){ref-type="fig"}C). Mature neuronal gene *ENO2* was expressed in both cultures, while GABAergic gene *GAD67* was only present in differentiated SKNs. Protein expression corroborated these findings ([Figure 5](#fig5){ref-type="fig"}D). Mature neuronal proteins NEUN and neurofilament were seen in differentiated SKNs. BETAIII-TUBULIN and MAP2 co-expression can also be seen in morphologically immature ([Figure 5](#fig5){ref-type="fig"}D; left) and mature stage differentiated SKNs ([Figure 5](#fig5){ref-type="fig"}D; right), while peripheral nervous system (PNS) neuron markers peripherin and P75NTR (when co-expressed with a neuronal cytoskeletal marker, [@bib21]) were not present. PNS glial protein MBP (Schwann cells), and CNS glial proteins GFAP (astrocytes) and OLIG2 (oligodendrocytes) were also absent. Positive control stains for these proteins can be seen in [Figure S7](#mmc1){ref-type="supplementary-material"}. Presynaptic vesicular protein BASSOON and punctate accumulation of the FM4-64FX membrane-affinity dye was also detected along the length of the cell processes as well as internalized within the soma, indicative of synaptic vesicle turnover ([Figure 5](#fig5){ref-type="fig"}E).Figure 5SKNs Are Neuronally Fate Restricted and Endogenously Upregulate Neuronal Specification Genes Following Differentiation(A) Representative images of SKN and NPC morphology at differentiation days 14 and 28. Scale bars, 50 μm.(B) Quantitative data of multipolar cell morphology in 28 day differentiated SKNs and NPCs. (^∗∗∗∗^p \< 0.0001; n = 3 independent experiments; mean ± SEM).(C) Gene expression analysis shows differentiated SKNs and NPCs both express mature neuronal genes. Unlike NPC cultures, SKNs also expressed GABAergic neuronal gene *GAD67*, and did not express glial marker gene *GFAP*. Canine brain isolate was used as a positive control and water a negative control.(D) Representative immunocytochemistry images of mature neuronal proteins BETAIII-TUBULIN (green) and MAP2 (red), NEUN, and NEUROFILAMENT. PNS neuronal proteins PERIPHERIN and P75NTR (same double stain as NEUROFILAMENT), and both CNS and PNS glial proteins GFAP, OLIG2, and MBP were not expressed in differentiated SKNs. For positive controls stains of these proteins see [Figure S7](#mmc1){ref-type="supplementary-material"}. Scale bars, 50 μm.(E) Punctate vesicle loading of membrane-affinity dye FM4-64FX within a differentiated SKN cell\'s neurites and soma, and expression of presynaptic vesicular protein BASSOON. Scale bars, 25 μm.(F) Differentiated SKNs downregulated neural stem cell genes *NES* (^∗∗∗∗^p = 0.0001) and *P75NTR* (^∗∗^p = 0.001), and upregulated cell-cycle exit gene C*DKN1A* (^∗∗^p = 0.007), known neuronal specification genes *ASCL1* (^∗^p = 0.04), *POU3F2, MYT1L*, and *NEUROD1,* oligodendrocyte repressor gene *DLX2*, neurotransmitter-associated genes *SLC17A7, SLC18A2, GABBR2* (^∗^p = 0.01), and *DAT1*, BASSOON gene *BSN* (^∗^p = 0.03), and brain-specific voltage-gated sodium channel gene *SCN8A* (n = 3 independent experiments; mean ± SEM).

qPCR analysis following differentiation revealed downregulation of proliferative markers *NES* (3-fold; ^∗∗∗∗^p = 0.0001) and *P75NTR* (4.9-fold; ^∗∗^p = 0.001), complemented by upregulation of the p21 gene *CDKN1A* (4.8-fold; ^∗∗^p = 0.007), signifying terminal differentiation ([Figure 5](#fig5){ref-type="fig"}F). Notably, significant upregulation of neural specification gene *ASCL1* was observed (27.8-fold; ^∗^p = 0.04), as well as trends toward increased expression for *POU3F2*, *MYT1L*, and *NEUROD*. SKN differentiation was also accompanied by upregulation of oligodendrocyte repressor gene *DLX2*, and of several neurotransmitter-associated genes including glutamate transporter *SLC17A7*, monoamine transporter *SLC18A2*, GABA receptor *GABBR2* (4.1-fold; ^∗^p = 0.01), and dopamine transporter *DAT1*. Significant upregulation of the BASSOON gene *BSN* (5-fold; ^∗^p = 0.03), and a trend toward upregulation of the voltage-gated sodium channel gene *SCN8A*, was also indicative of neuronal maturation ([Figure 5](#fig5){ref-type="fig"}F). Overall, these protein and gene expression patterns suggest that canine SKNs are highly neuronally committed.

Differentiated SKNs Possess Basic Neuronal and Synaptic Functionality *In Vitro* {#sec2.6}
--------------------------------------------------------------------------------

Over the differentiation period, SKNs displayed a steady hyperpolarization of resting membrane potential, with the majority of cells exhibiting resting membrane potentials analogous to mature functional neurons (≥−55 mV) at 25--28 days *in vitro* ([Figure 6](#fig6){ref-type="fig"}A). Functional voltage-gated ion channels were observed under voltage-clamp conditions ([Figure 6](#fig6){ref-type="fig"}B), and sub-threshold depolarization and graded regenerative responses were observed via current-clamp recordings as early as 14 days *in vitro* ([Figure 6](#fig6){ref-type="fig"}C). However, under these conditions mature action potentials were not recorded, and as such SKNs remained in an electrophysiologically immature neuronal state.Figure 6Differentiated SKNs Develop Basic Neuronal and Synaptic Functionality(A) SKN resting membrane potential hyperpolarized and approached physiological neuronal levels (≥−55 mV) during 28 days of differentiation (each time point represents readings from \>10 individual cells across n = 3 independent experiments). From *post hoc* analysis of multiple comparisons, days 25--28 were significantly different to days 12--14 only (F~2,\ 39~ = 4.28, ^∗^p = 0.02; mean ± SEM).(B) Example voltage-clamp recordings illustrating inward and outward voltage-gated ion channel currents in differentiated SKNs.(C) Current-clamp recordings of regenerative action potentials in a differentiated SKN.(D) Change in Fura-2AM calcium-affinity dye fluorescence intensity over time, demonstrated functional calcium channel response to (**+**) a depolarizing solution and potentiation of this response following (**++**) ATP-based co-activation.(E) Pseudocolor visualization of (D).

Calcium (Ca^2+^) influx via voltage-gated channels is known to accompany action potentials. Fura-2-acetoxymethyl ester calcium-affinity dye was therefore used as a higher-throughput method for detection of voltage-gated events. Calcium entry was observed by change in the 340/380 florescence signal ratio over time ([Figure 6](#fig6){ref-type="fig"}D) and focal shifts in pseudocolorized image intensity ([Figure 6](#fig6){ref-type="fig"}E), when normalized to baseline T0. Differentiated SKNs exposed to a depolarization solution of 129 mM KCl and 2 mM Ca^2+^ show rapid Ca^2+^ internalization (+). Interestingly, depolarization solution containing 100 μM ATP (**++**) induced an increased influx of Ca^2+^, with repeated spikes of calcium entry observed consistent with repeated voltage-gated events.

Discussion {#sec3}
==========

Adult skin is extraordinarily complex, comprised of several interactive stem cell niches that originate from ectodermal, mesenchymal, and neural crest cell lineages. Here, we show that the canine dermis can be used to isolate and propagate precursor cells that display an interesting combination of neural crest, neural stem, and mesenchymal markers. Further, SKN cell lines can be reliably produced from mature dogs, display a high degree of line-to-line stability, are homogeneous across multiple phenotypic markers, and *in vitro* are highly neuronally committed. SKNs are therefore a promising candidate for neural cell therapeutic applications.

Embryologically, brain and skin originate from the same ectodermal lineage. Many adult tissues, including skin, continue to harbor populations of multipotent stem cells. Rather than being necessarily restricted to the tissue-specific lineages of origin, an increasing number of studies suggest that their differentiation potential is diverse and strongly influenced by environmental stimuli. For example, under defined culture conditions, dental pulp stem cells are capable of generating CNS neurons, yet are neural crest-derived and accordingly developmentally restricted to the PNS ([@bib3]). Similar plasticity is seen in dermal-derived precursor cells. When SKPs (closely related to SKNs) are isolated from neural crest-derived skin tissue they generate not only PNS neural cell types but also CNS neurons ([@bib15]), and even mesenchymal osteogenic cells ([@bib30]). The converse is also possible: the dermal stem cell niche in ventral abdominal skin is non-neural crest in origin yet, despite this, SKPs derived from this niche are capable of generating neural crest-derived cell types ([@bib26]). SKNs in our study were isolated from ventral skin and therefore are likely to originate from the same non-neural crest-derived multipotent stem cells as ventral SKP cells.

Despite their similar origins, SKNs have several advantages over SKPs from a therapeutic perspective, including reliable homogeneous culture and strong neurogenic bias. Adherent culture is one potential reason for this increased uniformity, as observed in studies of neurogenic cells ([@bib27], [@bib10], [@bib43], [@bib22]). In our case, uniformity was seen both within and across lines. We observed less than 2% coefficient of variance for three key phenotypic markers (CD133, NESTIN, and P75NTR) across multiple cell SKN lines and have, to date, produced more than 50 such lines from different dogs with a greater than 85% success rate. Furthermore, for several markers (P75NTR, CD133, and NESTIN), the level of positive expression was \>97%, confirming that our protocol produces a reliably homogeneous SKN culture as required for clinical studies.

The pattern of SKN cell marker expression was unique, reflecting both their NPC-like properties (NESTIN and CD133) and dermal origins (PDGFRA and CD44). This pattern has some precedence, with human MSCs shown to spontaneously express neural linage markers SOX2, NESTIN, BETAIII-TUBULIN, and NEUROFILAMENT *in vitro* ([@bib16], [@bib38]). More generally, SKNs also exhibit upregulated and even unique expression of several genes associated with cell proliferation, cell adhesion, and cell migration. SKNs are hence an enriched population of neurogenic cells that may be well suited for survival and migration *in vivo*, a key factor that now requires empirical testing. Importantly, the absence of any genetic manipulation and observation that cell doubling tends to self-limit after four to five passages alongside downregulation of SOX2 further supports the safe use of these cells.

We found that SKNs are fate restricted by virtue of almost exclusive neuronal differentiation. Differentiated cells expressed a range of mature neuronal markers including synaptic and neurotransmitter-associated proteins. While these protein markers can also be found in PNS neurons, the absence of specific peripheral neuronal and glial proteins suggests that SKNs can mature *in vitro* into neurons compatible with the CNS. This neuronal fate bias may be linked to the endogenous upregulation of oligodendrocyte repressor gene, *DLX2* ([@bib41]), and spontaneous upregulation of several neural specification genes in response to a differentiation stimuli (high-dose BDNF). Indeed, these specification genes encode for the same four transcription factors (ASCL1, BRN2, MYTL1, and NEUROD) necessary for direct conversion of human somatic cells to iNs ([@bib39]).

Differentiated SKNs also possessed basic neuronal functionality including voltage-gated ion channels and ATP-potentiated calcium transients, as seen in CNS neurons ([@bib35]). However, mature action potentials remained elusive, suggesting that extended differentiation may be necessary for complete functional maturation into definitive neuronal subtypes. Indeed, embryonic stem cell-derived neural precursors have reportedly required up to 7 weeks to develop mature action potentials ([@bib28]). Nevertheless, global and focal gene expression data suggested that SKNs may possess a GABAergic and glutamatergic neuronal differentiation bias. This is in line with reports that similar adherent expansion of neural stem cells induces a bias toward GABAergic neurons ([@bib22]), an intriguing finding that can be followed up in future work. In general, we hope that the strong neurogenic potential of canine SKN cells can be exploited to overcome one of the more pressing deficits in the cell replacement field: poor neuronal yields and an *in vivo* bias toward glial differentiation ([@bib24], [@bib7]).

In summary, SKNs are capable of generating rich and uniform yields of mature neurons comparable with CNS neurons and may therefore have a role in replacement of lost brain cells. Having thoroughly characterized canine SKNs *in vitro*, we are now well placed to determine whether they are affected by disease-related signals and capable of generating structurally and functionally mature neurons *in vivo*.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

Mature dogs up to 6 years of age had abdominal skin tissue (≈6 cm^2^) harvested following owner consent. Abdominal skin has been shown to harbor neurogenic stem cells ([@bib56], [@bib21], [@bib59], [@bib26]) and is a practical region for future human clinical study as it is not frequently exposed to potentially mutagenic sunlight (UV radiation), and would represent a less-invasive harvest procedure for aged patients than alternatives such as facial skin ([@bib21]). Canine tissue use was approved by the Animal Care and Ethics Committee of the University of New South Wales.

Skin biopsies were divided into 1--2 mm^2^ pieces and digested in 0.1% Trypsin (Thermo Fisher Scientific Australia Pty Ltd, Scorseby, VIC, Australia) for 40 min at 37°C, followed by 0.1% DNAse (Roche Applied Science, Castle Hill, NSW, Australia) for 1 min at room temperature. The tissue was then mechanically dissociated and passed through a 40 μm cell strainer (BD Bioscience, Sydney, NSW, Australia), and centrifuged at 180 × *g* for 5 min.

SKNs were then established using our published protocol ([@bib59]). In brief, the dissociated cells were then re-suspended in serum-free complete medium consisting of 3:1 DMEM/Ham\'s F-12 Nutrient Mixture (DMEM/F12; Thermo Fisher Scientific), 1% Penicillin Streptomycin (Thermo Fisher Scientific), 20 ng/mL EGF (BD Bioscience, Sydney, NSW, Australia), 40 ng/mL bFGF (Thermo Fisher Scientific), and 2% B-27 supplement (Thermo Fisher Scientific). The cells were then seeded at a density of 100,000 cells/cm^2^. When resulting neurospheres reached 50--100 μm in diameter, they were dissociated using TrypLE Select (Thermo Fisher Scientific) for 5 min at 37°C. Cells were then re-suspended in complete medium and grown as an adherent monolayer by seeding at 10,000 cells/cm^2^ on 0.1% gelatin-coated flasks, and passaged when 80% confluent.

For FBT culture, the dissociated cells were re-suspended in 3:1 DMEM/F12 medium containing 10% fetal bovine serum (Thermo Fisher Scientific), 1% GlutaMAX (Thermo Fisher Scientific), and 1% penicillin streptomycin. Hereafter referred to as FDMEM, and seeded at a density of 100,000 cells/cm^2^.

NPCs were derived from subventricular zone brain isolates, following previously published protocols ([@bib17]).

Transcriptomic Analysis {#sec4.2}
-----------------------

RNA from three individual donor lines each of SKNs, NPCs, and FBTs were subjected to genome-wide transcriptomic analysis using an Affymetrix Canine Genechip Gene 1.0 ST array (Affymetrix, Santa Clara, CA, USA). The complete microarray data are available online at <https://www.ncbi.nlm.nih.gov/geo/> (accession number GEO: [GSE74714](ncbi-geo:GSE74714){#intref0015}).

Immunocytochemistry and Flow Cytometry {#sec4.3}
--------------------------------------

Cells fixed with 4% paraformaldehyde were permeabilized in 0.5% Triton X-100 for 30 min, then blocked using 10% normal donkey serum (Sigma-Aldrich, Castle Hill, NSW, Australia) for 1 hr prior to overnight incubation in diluted primary antibodies. Alexo Fluor 488 or 594 secondary antibody (Thermo Fisher Scientific) incubation, and DAPI counterstaining was then carried out prior to imaging on a Leica DMI3000B Microscope, or quantification using a MACSQuant Analyzer flow cytometer (Miltenyi Biotec Pty Ltd, Sydney, NSW, Australia).

Gene Expression {#sec4.4}
---------------

RNA was extracted using an illustra RNAspin Mini Isolation Kit (GE Healthcare, Little Chalfont, Buckinghamshire, UK) according to the manufacturer\'s instructions. cDNA was synthesized using Superscript III RT First Strand Synthesis System (Thermo Fisher Scientific). PCR amplification was then performed using Platinum *Taq* DNA Polymerase (Thermo Fisher Scientific). qRT-PCR was carried out using the CFX96 Real-Time PCR/C1000 thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA) using SsoFast EvaGreen Supermix (Bio-Rad Laboratories). Relative gene expression was calculated using endogenous *GAPDH* housekeeping gene.

Electrophysiology {#sec4.5}
-----------------

Whole-cell patch-clamp recordings were performed on differentiated SKN cells at room temperature (22.5°C ± 0.3°C). All membrane potentials were corrected for the liquid junction potential of 15.4 mV. Recordings were performed using an Axopatch-1D amplifier and digitized using pClamp 10.4 software and a Digidata 1440 interface (Molecular Devices, Sunnyvale, CA, USA) at 10 kHz, and filtered with an 8 pole Bessel filter at 2 kHz.

Calcium Imaging {#sec4.6}
---------------

Fura2-AM dye (Thermo Fisher Scientific) was used as a ratiometric calcium indicator. Fluorescence intensity was recorded while perfused in a 5 mM KCl, 0 mM Ca^2+^ baseline solution, followed by 129 mM KCl, 2 mM Ca^2+^, then 129 mM KCl, 2 mM Ca^2+^, and 100 μM ATP solutions.

Statistical Analysis {#sec4.7}
--------------------

Repeat experiments were conducted on biologically independent cell lines. Statistical analysis was performed using GraphPad Prism (GraphPad Software, La Jolla, CA, USA), analyzed by Student's t test or ANOVA for multiple comparisons and considered significant at p \< 0.05.

For further details of experimental procedures see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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[^1]: PI3K, phosphatidylinositol 3-kinase.
